CorMedix Inc. has announced a major asset purchase agreement with Heron Therapeutics, marking a significant step in its growth strategy. The agreement, finalized on November 8, 2026, allows CorMedix to acquire substantially all of Heron’s assets for a total consideration of $145 million in cash and stock. This acquisition is poised to enhance CorMedix’s portfolio in the pharmaceutical preparations sector, potentially reshaping its competitive landscape.
CorMedix Inc., a Delaware corporation, operates in the pharmaceutical preparations industry, specifically under the SIC code 2834. The company is listed on the Nasdaq under the ticker CRMD. Recent filings indicate a series of strategic moves by CorMedix, including this asset acquisition, aimed at bolstering its market position.
The asset purchase agreement entails CorMedix issuing 14,583,333 shares of its common stock and paying $145 million in cash, subject to adjustments based on Heron’s closing cash and net working capital. Notably, $2 million of the cash consideration will be held in escrow for potential post-closing adjustments. Furthermore, CorMedix will pay royalties based on the performance of certain products and may issue earn-out payments tied to sales milestones.
This transaction is likely to impact various stakeholders, including shareholders of both CorMedix and Heron Therapeutics. The agreement includes provisions for customary representations and warranties, as well as covenants that restrict both parties from engaging in certain competitive activities for specified periods following the closing.
Looking ahead, the completion of this asset sale is contingent upon obtaining stockholder approval from Heron and meeting other customary closing conditions, including regulatory approvals. The agreement is structured to ensure that both parties are committed to finalizing the transaction, with provisions for potential termination under specific circumstances.
Read Next
Zatlyn Michelle files recent executive transaction details
Treadway Anthony Shea sells shares in TriNet Group
Dicks Allan acquires 60,000 shares in Onterris, Inc.
WEX Inc. COO Deshaies sells 846 shares of company stock
Carla Todd Tharp Boosts Stake in Ring Energy with 50,000 Shares
Anderson Gregory Clark reports new equity transactions






